ARKK, QQQ, HIMS, APP & WULF Highlighted for Recovery and Bullish Exposure

Market_Chart
02-10 11:47

This week’s market highlights focus on ARK Innovation ETF (ARKK) versus QQQ, Hims & Hers Health (HIMS), AppLovin (APP) with its leveraged ETF APPX, and TeraWulf (WULF) with WULX.

ARKK continues to lag the Nasdaq over five years, while HIMS shows sharp volatility. APP has seen a rebound following a short-seller correction, offering potential upside, especially via APPX for magnified exposure. WULF hits multi-year highs, with WULX providing amplified bullish participation.

Overall, these names illustrate contrasting trajectories, volatility-driven opportunities, and potential turnarounds across tech, healthcare, and crypto-related sectors.

1. $ARK Innovation ETF(ARKK)$ VS $Invesco QQQ(QQQ)$

Cathie Wood's Ark Invest $ARKK is now down 38% over the last 5 years. Meanwhile, Nasdaq $QQQ has doubled over that same period.

2. $Hims & Hers Health Inc.(HIMS)$

Hims & Hers Health $HIMS Timberrrrrrrrrr 📉📉 What happened to all the X accounts that were promoting this? 😂

3. $AppLovin Corporation(APP)$ VS $Tradr 2X Long APP Daily ETF(APPX)$

AppLovin $APP jumps after short-seller CapitalWatch issues an apology and correction for its inaccurate allegations 🚨 Is this the beginning of a turn around for the stock?

For magnified bullish exposure, consider the Tradr 2X Long APP Daily ETF $Tradr 2X Long APP Daily ETF(APPX)$

4. $TeraWulf Inc.(WULF)$ VS $Tradr 2X Long WULF Daily ETF(WULX)$

TeraWulf $WULF hits highest closing price since 2021 🚨 Is the stock headed for price discovery? For magnified exposure, consider the Tradr 2X Long WULF Daily ETF $WULX

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment